(CF) Cystic Fibrosis StripAssay® & CF StripAssay® TUR

Oasis Diagnostics Corporation offers 2 kits for the detection of Cystic Fibrosis (CF). The  CF StripAssay® is a cost effective tool for identifying gene mutations indicative of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). The CF StripAssay® TUR is a kit that specifically identifies mutations present in the Turkish population.

CF StripAssay® Brochure

CF StripAssay® TUR Brochure

  • Kits are based on reverse-hybridization of biotinylated PCR products.
  • Minimal equipment required (thermal cycler, shaking water bath).
  • Technology combines probes for mutations and controls in a parallel array of allele-specific oligonucleotides.
  • Functions using immobilized oligos on a teststrip.
  • Strips show mutations by enzymatic color reaction visible to the naked eye.
  • Proprietary software package (Evaluator™) that aids in data interpretation, storage, and archiving.

Mutations Detected

Mutations detected by the kits are illustrated in the charts below:

CF StripAssay® Catalog 4-410

CF Chart

CF StripAssay® TUR Catalog 4-420

CF TUR Chart

 

Publications

6 A novel StripAssay for the detection of cystic fibrosis mutations in the Turkish population (Puehringer 2012)

24 Multicenter validation study of a novel StripAssay for cystic fibrosis (Oberkanins 2011)

Polymorphism in cardiovascular diseases (CVD) susceptibility loci in the azores islands (Portugal) (Raposo 2011)

Study of ACE Ins/Del polymorphism as a genetic risk factor for cardiovascular disease in the Iranian population (Kariminejad 2010)

Simultaneous detection of common cystic fibrosis mutations by reverse-hybridization teststrips (Puehringer 2010)

 

For Research Use Only [RUO]. Not for use in diagnostic procedures.